Page 2 - Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED May 01, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

121 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4111

Chi Sheng Pharma & Biotech
NT$25.850%-17.9%NT$1.5bn/aPE21.4xn/a3.9%

6550

Polaris Group
NT$70.206.2%-27.8%NT$50.6bn/aPS14903.2xn/an/a

6748

ACRO Biomedical
NT$26.35-29.0%-3.5%NT$1.6bn/an/an/an/a

6677

Anxo Pharmaceutical
NT$45.25-0.2%-2.0%NT$2.5bn/aPE75.7xn/a0%

6875

Pharmosa Biopharm
NT$73.5012.6%-8.4%NT$8.6bn/aPE1018.7xn/an/a

6814

Lukas Biomedical
NT$29.80-0.3%-22.2%NT$1.1bn/aPS4.7xn/an/a

6610

TWi Biotechnology
NT$12.054.3%-40.0%NT$1.1bn/aPB6.4xn/an/a

6919

Caliway Biopharmaceuticals
NT$384.00-1.8%183.9%NT$53.5bn/aPS1375.1xn/an/a

6547

Medigen Vaccine Biologics
NT$51.60-0.8%-18.7%NT$17.0bn/aPS43.5xn/an/a

6973

U-Neuron Biomedical
NT$52.90-2.9%n/aNT$1.6bn/an/an/an/a

6892

Taiwan Bio Therapeutics
NT$37.601.1%-4.1%NT$1.9bn/an/an/an/a

1720

Standard Chemical & Pharmaceutical
NT$63.201.6%-15.7%NT$11.3bNT$80.00PE13.5xn/a4.3%

4168

GlycoNex Incorporation
NT$25.30-0.4%-23.3%NT$2.7bn/aPS1081.3xn/a0%

4170

Vectorite Biomedical
NT$15.35-2.2%n/aNT$671.9mn/aPS12xn/an/a

1762

Chunghwa Chemical Synthesis & Biotech
NT$46.303.1%-52.8%NT$3.6bNT$48.00PE13.6xn/a1.7%

1760

Panion & Bf Biotech
NT$97.500.4%-41.6%NT$8.2bn/aPE108.3xn/a1.5%

6885

BRIM Biotechnology
NT$31.20-6.6%-59.8%NT$3.6bn/aPS40128.1xn/an/a

4160

Genetics Generation Advancement
NT$49.80-9.9%19.1%NT$1.3bn/aPE44.3xn/a1.0%

6492

Senhwa Biosciences
NT$41.451.8%-20.7%NT$3.7bn/aPS3696.8xn/an/a

6580

TaiRx
NT$38.05-0.8%13.1%NT$4.2bn/aPS825.1xn/an/a

6810

Bio Preventive Medicine
NT$37.100.4%-5.7%NT$1.3bn/an/an/an/a

6562

UBI Pharma
NT$14.15-10.7%-63.6%NT$1.7bn/aPE2082.7xn/a0%

6696

Lin BioScience
NT$94.7020.9%-43.6%NT$7.4bn/aPB3.5xn/an/a

6808

3D Global Biotech
NT$33.751.8%19.0%NT$2.3bn/aPS109.3xn/an/a
Page 2 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.